Further, Pharmacy Times reported Among patients with a pre-existing psychiatric diagnosis who started treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, more than one-third had a psychiatric emergency department visit within 60 days of GLP-1 initiation. Prediction 3: High Rates of Attrition In July 2024, NBC News reported that most people are no longer on GLP-1s after
These can include: Upper abdominal cramping Bloating or gas Mild nausea If you have a very sensitive stomach or active gastritis alongside your reflux, these symptoms could be misinterpreted as a flare-up
To view or add a comment, sign in A routine prescription
For the study, Qeadan, who was assisted by Benjamin Tingey, database manager and biostatistician, and Ashlie McCunn (MPH 23), an epidemiologist at Parkinson, accessed the Oracle Health Real-World dataset, which provides masked records on 115 million patients for research purposes
HuBOuyangYZhaoTWangZYanQQianQet alAntioxidant hydrogels: Antioxidant mechanisms, design strategies, and applications in the treatment of oxidative stress-related diseases
van Greevenbroek, Anke Wessel Cardiovascular Diabetology.2025;[Epub] CrossRef Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates Magdy Abdelhamid, Mostafa M Abdrabou, Emanuel Faris, Sameh El Kafas, Mohamed Hosny, Ahmed Hassan Cardiac Failure Review.2025;[Epub] CrossRef Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu Journal of Diabetes.2024;[Epub] CrossRef A randomized, doubleblind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARDJPN) Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto Diabetes, Obesity and Metabolism.2024
